Sopharma AD (SPH) - Total Liabilities

Latest as of September 2025: zł1.04 Billion PLN ≈ $285.26 Million USD

Based on the latest financial reports, Sopharma AD (SPH) has total liabilities worth zł1.04 Billion PLN (≈ $285.26 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Sopharma AD to track the company's year-over-year net asset growth rate.

Sopharma AD - Total Liabilities Trend (2011–2024)

This chart illustrates how Sopharma AD's total liabilities have evolved over time, based on quarterly financial data. See SPH free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Sopharma AD Competitors by Total Liabilities

The table below lists competitors of Sopharma AD ranked by their total liabilities.

Company	Country	Total Liabilities
MAC Copper Ltd AU:MAC	Australia	AU$870.02 Million
Virtus Investment Partners, Inc. NASDAQ:VRTS	USA	$2.88 Billion
Suzhou Shihua New Material Technology Co Ltd SHG:688093	China	CN¥119.49 Million
McEwen Mining Inc. TO:MUX	Canada	CA$319.81 Million
Eyepoint Pharmaceuticals Inc NASDAQ:EYPT	USA	$51.51 Million
Kunshan Kersen Science & Tech SHG:603626	China	CN¥2.55 Billion
Marten Transport Ltd NASDAQ:MRTN	USA	$182.14 Million
Xinjiang Tianye Co Ltd SHG:600075	China	CN¥11.59 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Sopharma AD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sopharma AD market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sopharma AD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sopharma AD (2011–2024)

The table below shows the annual total liabilities of Sopharma AD from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	zł953.18 Million ≈ $262.33 Million	+25.33%
2023-12-31	zł760.54 Million ≈ $209.31 Million	+41.45%
2022-12-31	zł537.67 Million ≈ $147.97 Million	-1.55%
2021-12-31	zł546.11 Million ≈ $150.30 Million	-19.16%
2020-12-31	zł675.52 Million ≈ $185.91 Million	+12.68%
2019-12-31	zł599.50 Million ≈ $164.99 Million	+19.40%
2018-12-31	zł502.07 Million ≈ $138.18 Million	+5.12%
2017-12-31	zł477.62 Million ≈ $131.45 Million	+29.79%
2016-12-31	zł368.00 Million ≈ $101.28 Million	-2.64%
2015-12-31	zł377.99 Million ≈ $104.03 Million	-2.01%
2014-12-31	zł385.73 Million ≈ $106.16 Million	+4.25%
2013-12-31	zł370.01 Million ≈ $101.83 Million	+4.50%
2012-12-31	zł354.06 Million ≈ $97.44 Million	+13.93%
2011-12-31	zł310.78 Million ≈ $85.53 Million	--

About Sopharma AD

WAR:SPH Poland Medical Distribution

Market Cap

$1.08 Billion

zł3.93 Billion PLN

Market Cap Rank

#8447 Global

#43 in Poland

Share Price

zł7.56

Change (1 day)

+0.00%

52-Week Range

zł7.12 - zł12.75

All Time High

zł17.83